Sentinel lymph node biopsy in cT1-2N0 minor salivary gland cancer in oral cavity
In patients with cT1/2N0 oral mSGC, SLNB proved to be both technically feasible and oncologically safe. When contrasted with observation, SLNB was associated with enhanced regional control, particularly recommending its use for cases of cT2 mSGC arising from the tongue or the floor of the mouth.
Authors
- Qigen Fang (ORCID: https://orcid.org/0000-0002-7303-1030)
- Peng Li (ORCID: https://orcid.org/0000-0002-7820-4412)
- Xu Zhang (ORCID: https://orcid.org/0000-0002-3662-7759)
- Wei Du (ORCID: https://orcid.org/0000-0001-8271-6704)
Institutions
- Zhengzhou University (CN)
- Henan Cancer Hospital (CN)
Publication Details
- Journal
- BMC Cancer
- Published
- 2024-11-04
- DOI
- https://doi.org/10.1186/s12885-024-13107-7
- Citations
- 2
- Primary Topic
- Salivary Gland Tumors Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.15